Minerva Neurosciences | NERV - Ebitda





Ebitda Changement Date
Acadia Pharmaceuticals USD 35.76M 447K 2025-09
Adma Biologics USD 73.59M 14.85M 2025-12
ALKERMES USD 100.31M 21.24M 2025-12
Alterity Therapeutics Limited AUD -7.72M 2.99M 2023-06
AstraZeneca USD 5.23B 272M 2025-09
BioCryst Pharmaceuticals USD 51.7M 30.14M 2025-09
Bristol-Myers Squibb USD 4.24B 967M 2025-09
Cipla INR 12.55B 6.4B 2025-12
Clal Biotechnology ILS -5.3M 2.09M 2022-12
Compugen USD -7.89M 536K 2025-09
CSL USD 3.13B 1.17B 2025-12
Eli Lilly USD 7.88B 378.1M 2025-09
Esperion Therapeutics USD -9.93M 24.99M 2025-09
GlaxoSmithKline GBP 3.36B 179M 2025-09
Grifols EUR 482.04M 7.04M 2025-09
Halozyme Therapeutics USD 21.9M 226.34M 2025-12
Ionis Pharmaceuticals USD -157.12M 307.36M 2025-09
J&J USD 9.52B 389M 2025-09
Merck USD 8.39B 1.97B 2025-09
Minerva Neurosciences USD -4.36M 1.71M 2024-09
Neurocrine Biosciences USD 218.4M 28.3M 2025-12
Novartis USD 4.77B 1.11B 2025-12
Novavax USD 19.36M 190.79M 2025-12
Pfizer USD 6.08B 351M 2025-09
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 4.84B 2.95B 2025-09
Takeda JPY 448.13B 173.98B 2025-12
Vanda Pharmaceuticals USD -8.31M 2.37M 2024-12